MedTrace Logo

Observation of Benefits for Patients Implanted With a Hearing Implant of the Company Cochlear

NCT02004353 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1518

Last updated 2021-11-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to collect patient related benefit data following treatment for permanent hearing loss with a hearing implant from the company Cochlear over a period of 2 years post treatment.

Assessment of benefits is based on standard questionnaires of hearing ability and quality of life in general.

Conditions

Interventions

DEVICE

Cochlear® Hearing Implants

Market approved hearing implants including: Nucleus Cochlear implants, Nucleus Auditory Brainstem Implants, Cochlear Baha implants, Cochlear Acoustic Implants

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Bart Volckaerts · Cochlear

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2020-06-23
Completion
2020-07-31

Countries

  • Argentina
  • Austria
  • Belgium
  • Brazil
  • Colombia
  • France
  • Germany
  • Hungary
  • Netherlands
  • Poland
  • Portugal
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02004353 on ClinicalTrials.gov